Peptide index

Apex Peptide Index™

Melanotan 1 (MT-1)

Synthetic melanocortin peptide analogueSKIN & CONNECTIVE TISSUELEVEL 01 · Basic biology

Also referred to as: MT-1 · Melanotan I

Overview

Melanotan 1 is an engineered peptide intended to reproduce aspects of the activity of endogenous alpha-melanocyte-stimulating hormone. It has been investigated in relation to pigment formation, while the supplied guide also discusses cosmetic interest in darker skin coloration.

0/3 selected

Biological background

Alpha-melanocyte-stimulating hormone participates in the biological regulation of skin coloration. Melanin contributes to the skin's response to ultraviolet radiation, but greater pigmentation should not be interpreted as establishing protection against skin cancer.

Mechanism

The proposed mechanism involves mimicking a natural hormonal signal associated with melanin synthesis. The notes link this process to changes in skin coloration but provide no receptor-specific findings or experimental measurements.

  1. 01

    Molecular target

  2. 02

    Cellular signal

  3. 03

    Biological process

Research areas

Pigment BiologyMelanin SynthesisUltraviolet ResponseCutaneous Safety

Evidence

LEVEL 01 · Basic biology

A biological mechanism or molecular interaction is described. No claim about human outcomes.

Evidence levels reflect the state of documented research only. They are not rankings of popularity, quality or suitability, and a higher level never implies that a compound is an approved medicine.

What the source states

The source presents the compound as having originated from efforts to investigate whether increasing pigmentation could lower the risk of skin malignancy. It also describes interest in appearance-related tanning and possible effects on ultraviolet responses and skin condition. These statements are presented without supporting study details and do not establish preventive or therapeutic benefit.

Source: The Complete Guide to Peptides: Unlocking the Secrets to Health, Healing and Longevity — Hack Smith, Chapter 6, Introduction to Peptides (page references not verified)

Summarised in our own wording from the cited reference. The reference is a popular guide, not peer-reviewed literature; its statements are reported here as source claims rather than established facts.

Dosage, reconstitution and administration guidance is deliberately excluded from this platform.

What remains uncertain

The supplied material does not establish the strength of evidence for its proposed benefits or distinguish experimental findings from anecdotal reports. Sustained effects on pigment-producing cells and endocrine signaling remain insufficiently characterized in these notes.

Safety information

Safety data are limited in the supplied material, despite the guide's favorable characterization of tolerability. The guide lists facial reddening, gastrointestinal symptoms, occasional appetite changes, and increased prominence of freckles or other pigmentation changes as possible adverse effects. This summary is educational and is not medical advice.

Regulatory context

Research-stage compound unless otherwise established by a competent authority. Regulatory classification differs between jurisdictions and can change over time; nothing here indicates marketing authorisation.

References

Primary reference for this entry:

The Complete Guide to Peptides: Unlocking the Secrets to Health, Healing and Longevity — Hack Smith, Chapter 6, Introduction to Peptides (page references not verified)

Suggested literature search terms taken from the source. They are search starting points, not citations to specific studies.

  • Melanotan 1 tanning peptide
  • Melanotan 1 skin pigmentation and UV protection
  • Melanotan 1 side effects and safety

Editorial record

Editorial status
source reviewed
Last updated
2026-09-14
Last reviewed
2026-09-13
Language
EN

Flagged for editorial review

  • · Evidence rating reflects supplied notes, not a comprehensive literature assessment
  • · Development-history claim requires verification
  • · Ultraviolet-response claims do not establish cancer prevention
  • · Broad skin-benefit terminology lacks defined outcomes
  • · Tolerability and appetite claims lack supporting references

Disclaimer

APEX PHARMA 360® provides scientific and educational information for informational purposes only. The information presented on this platform is not intended to diagnose, treat, cure or prevent any disease and does not constitute medical advice, medical treatment or a recommendation to use any particular substance or compound. Scientific research and regulatory status can change over time and may differ between jurisdictions. Experimental or research-stage compounds should not be interpreted as approved medicines. Always consult an appropriately qualified healthcare professional for individual medical questions and verify applicable laws and regulatory requirements in your jurisdiction.